These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 21948962)
41. The efficacy and tolerability of sildenafil in patients with moderate-to-severe pulmonary hypertension. Bharani A; Mathew V; Sahu A; Lunia B Indian Heart J; 2003; 55(1):55-9. PubMed ID: 12760589 [TBL] [Abstract][Full Text] [Related]
42. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial. Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181 [TBL] [Abstract][Full Text] [Related]
43. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension. Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512 [TBL] [Abstract][Full Text] [Related]
44. Chronic oral sildenafil therapy in severe pulmonary artery hypertension. Kothari SS; Duggal B Indian Heart J; 2002; 54(4):404-9. PubMed ID: 12462669 [TBL] [Abstract][Full Text] [Related]
45. Effects of sildenafil citrate on five dogs with Eisenmenger's syndrome. Nakamura K; Yamasaki M; Ohta H; Sasaki N; Murakami M; Bandula Kumara WR; Takiguchi M J Small Anim Pract; 2011 Nov; 52(11):595-8. PubMed ID: 21985577 [TBL] [Abstract][Full Text] [Related]
46. Impact of sildenafil on survival of patients with idiopathic pulmonary arterial hypertension. Zeng WJ; Sun YJ; Gu Q; Xiong CM; Li JJ; He JG J Clin Pharmacol; 2012 Sep; 52(9):1357-64. PubMed ID: 21956607 [TBL] [Abstract][Full Text] [Related]
47. Eisenmenger syndrome in the adult--experience with new drugs for the treatment of pulmonary hypertension. Agapito AF; Sousa L; Oliveira JA; Feliciano J; Cacela D; Quininha J Rev Port Cardiol; 2005 Mar; 24(3):421-31. PubMed ID: 15929625 [TBL] [Abstract][Full Text] [Related]
48. Safety and tolerability of bosentan in adults with Eisenmenger physiology. Gatzoulis MA; Rogers P; Li W; Harries C; Cramer D; Ward S; Mikhail GW; Gibbs JS Int J Cardiol; 2005 Jan; 98(1):147-51. PubMed ID: 15676179 [TBL] [Abstract][Full Text] [Related]
49. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Diller GP; van Eijl S; Okonko DO; Howard LS; Ali O; Thum T; Wort SJ; Bédard E; Gibbs JS; Bauersachs J; Hobbs AJ; Wilkins MR; Gatzoulis MA; Wharton J Circulation; 2008 Jun; 117(23):3020-30. PubMed ID: 18519847 [TBL] [Abstract][Full Text] [Related]
50. Dramatic beneficial effects of sildenafil in recurrent massive pulmonary embolism. Ganière V; Feihl F; Tagan D Intensive Care Med; 2006 Mar; 32(3):452-4. PubMed ID: 16450094 [TBL] [Abstract][Full Text] [Related]
51. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Giardini A; Balducci A; Specchia S; Gargiulo G; Bonvicini M; Picchio FM Eur Heart J; 2008 Jul; 29(13):1681-7. PubMed ID: 18534975 [TBL] [Abstract][Full Text] [Related]
52. Acute hemodynamic effects of single-dose sildenafil when added to established bosentan therapy in patients with pulmonary arterial hypertension: results of the COMPASS-1 study. Gruenig E; Michelakis E; Vachiéry JL; Vizza CD; Meyer FJ; Doelberg M; Bach D; Dingemanse J; Galiè N J Clin Pharmacol; 2009 Nov; 49(11):1343-52. PubMed ID: 19755415 [TBL] [Abstract][Full Text] [Related]
53. One year efficacy and safety of oral sildenafil treatment in severe pulmonary hypertension. Samarzija M; Zuljević E; Jakopović M; Sever B; Knezević A; Dumija Z; Vidjak V; Samija M Coll Antropol; 2009 Sep; 33(3):799-803. PubMed ID: 19860106 [TBL] [Abstract][Full Text] [Related]
54. Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension. Perez-Villa F; Farrero M; Sionis A; Castel A; Roig E J Heart Lung Transplant; 2010 Jul; 29(7):817-8. PubMed ID: 20363156 [No Abstract] [Full Text] [Related]
56. Sarcoidosis-associated pulmonary hypertension: acute vasoresponsiveness to inhaled nitric oxide and the relation to long-term effect of sildenafil. Milman N; Svendsen CB; Iversen M; Videbaek R; Carlsen J Clin Respir J; 2009 Oct; 3(4):207-13. PubMed ID: 20298406 [TBL] [Abstract][Full Text] [Related]
57. [Sildenafil and nitric oxide inhalation in neonatal pulmonary hypertension. Three case reports]. Cavallaro G; Agazzani E; Andaloro L; Bottura C; Cristofori G; Mussini P; Sacco F; Compagnoni G Pediatr Med Chir; 2008; 30(3):149-55. PubMed ID: 19024859 [TBL] [Abstract][Full Text] [Related]
58. Repair of atrial septal defect with Eisenmenger syndrome after long-term sildenafil therapy. Kim YH; Yu JJ; Yun TJ; Lee Y; Kim YB; Choi HS; Jhang WK; Shin HJ; Park JJ; Seo DM; Ko JK; Park IS Ann Thorac Surg; 2010 May; 89(5):1629-30. PubMed ID: 20417794 [TBL] [Abstract][Full Text] [Related]
59. Long-term treatment with sildenafil in chronic thromboembolic pulmonary hypertension. Reichenberger F; Voswinckel R; Enke B; Rutsch M; El Fechtali E; Schmehl T; Olschewski H; Schermuly R; Weissmann N; Ghofrani HA; Grimminger F; Mayer E; Seeger W Eur Respir J; 2007 Nov; 30(5):922-7. PubMed ID: 17690123 [TBL] [Abstract][Full Text] [Related]
60. Efficacy and safety of high dose generic sildenafil in Thai patients with pulmonary arterial hypertension. Durongpisitkul K; Pornrattanarungsi S; Panjasamanvong P; Chungsomprasong P J Med Assoc Thai; 2011 Apr; 94(4):421-6. PubMed ID: 21591526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]